Atenolol acetate

Atenolol acetate is a derivative of atenolol, a widely used selective β₁-adrenergic receptor blocker prescribed for conditions including hypertension, angina, and post-myocardial infarction care. Atenolol acetate is typically synthesized through enzymatic or chemical acetylation of atenolol. For instance, lipase-catalyzed kinetic resolution has been employed to produce enantiomerically pure (S)-atenolol acetate. This method utilizes Candida rugosa lipase and isopropenyl acetate as the acetylating agent, achieving high enantiomeric excess (ee) values. It is grouped under the following drug class(es): Beta blockers. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Atenolol monoacetate and 4-[2-(Acetyloxy)-3-[(1-methylethyl)amino]propoxy]benzeneacetamide. Its PubChem CID is 551861.

CAS No 250579-95-4
Molecular Formula C16H24N2O4
Molecular Weight 308.37 g/mol
Synonyms [1-[4-(2-amino-2-oxoethyl)phenoxy]-3-(propan-2-ylamino)propan-2-yl] acetate

Frequently Asked Questions